Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-01-18-Speech-2-440-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-01-18"^^xsd:date2
dcterms:Is Part Of	lp_eu:Patients’ rights in cross-border healthcare (debate)2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20110118.19.2-440-000"2
lpv:hasSubsequent	lp_eu:2011-01-18-Speech-2-441-0002
lpv:speaker	lp:Gilles Pargneaux2
lpv:spokenAs	member; Delegation for relations with Canada (2009-09-16--2014-06-30)3 unknown; Parti socialiste (2009-07-14--2014-06-30)3 member; ENVI (2009-07-16--2012-01-18)3 substitute; Delegation for relations with the United States (2009-09-16--2012-07-03)3 member; S&D (2009-07-14--2014-06-30)3 substitute; TRAN (2009-07-16--2012-01-18)3
lpv:translated text	"Mr President, Mrs Győri, Commissioner, first of all, allow me to express our satisfaction regarding the progress made by the directive that we are going to adopt tomorrow. For years, only the Court of Justice of the European Union has settled disputes regarding cross-border healthcare and patients’ rights. Today, patient mobility is no longer an uncommon phenomenon in Europe, but has become a part of everyday life. Cross-border treatment now represents 1% of total health expenditure in Europe. We should not, however, confuse patient mobility with the medical tourism that has developed over recent years. The latter is becoming organised and, unfortunately, is proving to be increasingly profitable. Health is gradually becoming a competitive market. A German goes to Hungary for dental treatment, a British national – if he has the means – goes to France so as to be operated on more quickly. There are numerous examples of this. However, we must ensure that health is not treated as a commodity, so that we are all equal. This is why, over the last three years, we have defended the principle of prior authorisation by the Member State of affiliation for hospital and non-hospital treatment. I would like to pay tribute to the work of the rapporteurs – Mrs Grossetête and our socialist rapporteur, Mrs Roth-Behrendt, whom I would particularly like to congratulate – which has enabled significant progress to be made, such as, for example, the reimbursement of care, the establishment of national contact points and European reference networks, the treatment of rare diseases and enhanced cooperation between the Member States. Mr President, Commissioner, our work is not finished. We need to go further, beyond the progress that has been made, in order to eliminate the disparities that we still have in Europe, and I know that together, we can ensure that European patients and citizens receive equal treatment."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph